US FTC's Ferguson will take part in insulin pricing suit against PBMs
MLex Summary: US Federal Trade Commission Chairman Andrew Ferguson has decided to no longer recuse himself from the agency’s proceeding against pharmacy benefit managers. See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article